Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences? | J Appl Genet | 2022 | 34984663 | PubTator, text mining | PubMed |
| Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network. | J Ovarian Res | 2022 | 34983607 | PubTator, text mining | PubMed |
| Long non-coding RNA HOXA11 antisense RNA upregulates spermatogenesis-associated serine-rich 2-like to enhance cisplatin resistance in laryngeal squamous cell carcinoma by suppressing microRNA-518a. | Bioengineered | 2022 | 34974809 | PubTator, text mining | PubMed |
| microRNA-10a-5p from gastric cancer cell-derived exosomes enhances viability and migration of human umbilical vein endothelial cells by targeting zinc finger MYND-type containing 11. | Bioengineered | 2022 | 34969361 | PubTator, text mining | PubMed |
| A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2. | Infect Genet Evol | 2022 | 34954105 | PubTator, text mining | PubMed |
| Emerging role of non-coding RNAs in the course of HIV infection. | Int Immunopharmacol | 2022 | 34942460 | PubTator, text mining | PubMed |
| Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer. | Mol Ther Nucleic Acids | 2022 | 34938606 | PubTator, text mining | PubMed |
| MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer's disease and amyotrophic lateral sclerosis. | Neural Regen Res | 2022 | 34916411 | PubTator, text mining | PubMed |
| Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. | J Cell Mol Med | 2022 | 34907642 | PubTator, text mining | PubMed |
| Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study. | Arch Gynecol Obstet | 2022 | 34889994 | PubTator, text mining | PubMed |
| Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review. | J Diabetes Investig | 2022 | 34859606 | PubTator, text mining | PubMed |
| ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9. | J Cell Mol Med | 2022 | 34850551 | PubTator, text mining | PubMed |
| Circ_0005033 is an oncogene in laryngeal squamous cell carcinoma and regulates cell progression and Cisplatin sensitivity via miR-107/IGF1R axis. | Anticancer Drugs | 2022 | 34845162 | PubTator, text mining | PubMed |
| CD47 interactions with exportin-1 limit the targeting of m7G-modified RNAs to extracellular vesicles. | J Cell Commun Signal | 2022 | 34841476 | PubTator, text mining | PubMed |
| FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577. | Oncol Rep | 2022 | 34821374 | PubTator, text mining | PubMed |
| Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients. | Br J Cancer | 2022 | 34811506 | PubTator, text mining | PubMed |
| Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research. | Br J Cancer | 2022 | 34811504 | PubTator, text mining | PubMed |
| CircSLC7A6 promotes the progression of Wilms' tumor via microRNA-107/ ABL proto-oncogene 2 axis. | Bioengineered | 2022 | 34787058 | PubTator, text mining | PubMed |
| Knockdown of lncRNA NEAT1 suppresses proliferation and migration, and induces apoptosis of cervical cancer cells by regulating the miR‑377/FGFR1 axis. | Mol Med Rep | 2022 | 34779493 | PubTator, text mining | PubMed |
| The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword. | Mol Biol Rep | 2022 | 34657251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=52